Chicago-based logistics real estate firm First Industrial Realty Trust, Inc. has authorized a quarterly common stock dividend of $0.50 per share. The payout is scheduled for distribution on October 19, 2026, to all shareholders of record at the close of business on September 30, 2026.
Shareholders of Wyndham Hotels & Resorts are set to receive a quarterly cash dividend of $0.43 per share, as confirmed by the company’s board of directors on August 13. The payout is scheduled for distribution on September 30 to all investors of record by the close of business on September 15.
Investors who held Primoris Services Corporation stock between August 2025 and June 2026 face a September 21 deadline to join a securities fraud class action. The lawsuit, spearheaded by Glancy Prongay Wolke & Rotter LLP, alleges the company obscured systemic failures in its renewable energy project forecasting and cost estimation.
Fremont-based Lam Research plans to pour more than $3 billion into its global laboratory network over the next five years. The initiative aims to boost the company’s experimental capacity by over 50%, a strategic move designed to keep pace with the intensifying demand for AI-driven semiconductor innovation.
Executives from Huntington-based Energy Services of America will outline the company's growth trajectory and industrial service capabilities at two major investor forums this autumn. Management representatives are slated to engage with institutional stakeholders in Chicago and New York to discuss operations across the mid-Atlantic and Central United States.
Metalla Royalty & Streaming reported record financial results for the second quarter of 2026, with revenue reaching $5.2 million and Adjusted EBITDA climbing to $3.9 million. The company’s growth was fueled by increased output from its producing assets and the start of inaugural royalty payments from Agnico Eagle Mines' Amalgamated Kirkland project.
Health In Tech, an AI-driven InsurTech platform based in Stuart, Florida, reported a net loss of $2.5 million for the second quarter of 2026, shifting from a $0.6 million profit in the same period last year as the company funneled capital into technology development and sales infrastructure.
Massachusetts has issued an emergency order to restrict the sale of concentrated and synthetic kratom products, marking a significant escalation in state-level oversight. The move aims to curb the availability of potent, unregulated substances that health experts warn carry risks ranging from liver toxicity to respiratory depression and overdose.
A 19 percent hike in quarterly payouts marks the sixteenth consecutive year of dividend growth for Cboe Global Markets. The Chicago-based exchange operator announced a new rate of $0.86 per share for the third quarter of 2026, signaling sustained capital returns for its shareholders following a previous $0.72 distribution.
Shareholders of MDU Resources Group will see a 3.6% boost to their quarterly dividend, bringing the payout to 14.5 cents per share. The move, effective October 1, coincides with a strategic recalibration of the company’s long-term payout targets to better balance capital investment with investor returns.
Salt Lake City-based Co-Diagnostics reported a net loss of $6.3 million for the second quarter of 2026, narrowing its deficit from $7.7 million in the same period last year as the company shifts focus toward FDA submissions and international manufacturing expansion for its molecular testing technology.
AudioEye marked its forty-second consecutive quarter of sequential revenue growth, reporting $10.7 million for the second quarter of 2026. Despite a GAAP net loss of $0.9 million, the digital accessibility firm achieved record adjusted EBITDA of $3.0 million, signaling a shift toward sustained free cash flow generation.
Conflict lead: While HawkEye 360 reported a sharp 87% revenue surge to $49.8 million for the second quarter of 2026, the defense technology firm simultaneously posted a net loss of $15.3 million, highlighting the aggressive capital investment required to sustain its rapid international expansion.
Inhibrx Biosciences posted a net loss of $36.7 million for the second quarter of 2026, as the San Diego-based firm increased research spending to advance its oncology pipeline. The company is currently navigating two clinical programs while securing fresh capital to bolster its balance sheet for upcoming regulatory milestones.
A 36.4% single-day stock collapse has prompted a securities class action against Photronics, Inc. The lawsuit, filed by Robbins LLP, claims the company misled shareholders about product demand and operational bottlenecks between December 2025 and May 2026, leaving investors with significant losses and a September 4, 2026, deadline to seek lead plaintiff status.
Only 15% of modern organizations maintain dedicated geopolitical intelligence capabilities, leaving a dangerous gap between risk awareness and effective analysis. To bridge this divide, the Society for Geopolitics has appointed former CIA officer Dr. Angela Lewis and Emergent Risk International’s Kieran O'Leary to its advisory board.
Investors are turning their attention to San Francisco as Docusign prepares to disclose its financial performance for the second quarter of fiscal 2027. The company confirmed it will release the results following the close of U.S. markets on Thursday, September 3, 2026, marking a key update for its stakeholders.
Shares of Boqii Holding Limited experienced significant volatility on August 12, 2026, prompting the Shanghai-based pet platform to address the market movement. Under NYSE American regulations, the company issued a formal statement clarifying that no undisclosed business developments or internal material changes occurred to justify the recent fluctuations.
After a decade of development and over C$96 million in investment, Moltex Energy has agreed to sell its advanced nuclear technology portfolio to Nuclea Energy. The acquisition, which follows a competitive bidding process, includes patents for the Waste to Stable Salt recycling system and the Stable Salt Reactor designs.
Vuzix Corporation reported a net loss of $7.6 million for the second quarter of 2026, as the Rochester-based smart glasses manufacturer navigates a period of transition. Despite a 14% revenue decline to $1.1 million, the company is doubling down on waveguide production and enterprise-focused AI integration for its upcoming product cycles.
Midland-based seismic data provider Dawson Geophysical reported a $3.4 million net loss for the second quarter of 2026, even as the company marked its fourth consecutive quarter of positive Adjusted EBITDA. The results reflect ongoing capital investments in high-density seismic technology and costs associated with a potential transaction involving controlling shareholder Wilks Brothers.
With first-half revenue climbing 112% to $1.4 million, VolitionRx is shifting its commercial strategy toward aggressive licensing negotiations. The epigenetics firm is currently courting over a dozen global diagnostic companies, aiming to turn its proprietary liquid biopsy and cancer-detection technologies into recurring royalty streams and milestone payments.
Shareholders of record by September 1, 2026, are set to receive a quarterly cash payout of $0.06 per share from HireQuest, Inc. The Goose Creek-based staffing franchisor confirmed the distribution date for mid-September, maintaining its current financial commitment to investors amid broader market operations.
Charlotte-based cbdMD reported a 20% year-over-year revenue increase for the third fiscal quarter of 2026, reaching $5.6 million. While wholesale growth and the integration of Bluebird Botanicals bolstered top-line figures, one-time legal and acquisition costs contributed to a net loss of $1.2 million.
Content production often stalls when teams repeatedly reset their understanding of a narrative, a friction point that leads to inconsistencies in global media. Burbank-based localization firm Iyuno is addressing this with CLOE, a multi-agent AI architecture designed to maintain persistent context across complex workflows like dubbing and subtitling.
Cineverse Corp. reported fiscal first-quarter revenue of $30.6 million, a 175% jump from the previous year, as the company pivots toward a tech-heavy streaming model. Despite a net loss, the Los Angeles-based firm achieved an adjusted EBITDA of $0.5 million, signaling a turnaround driven by recent strategic acquisitions.
Aethlon Medical has entered the final cohort of its Phase 1 oncology study in Australia, marking a pivotal step in testing its Hemopurifier device. The San Diego-based firm reported a narrowed operating loss for the first quarter of fiscal 2027, even as it moves to bolster its cash position through recent equity financing.
With over $1 billion in cash and marketable securities, Nektar Therapeutics has solidified its financial position to sustain operations through the third quarter of 2028. The company is now aggressively advancing its lead immunology program, rezpegaldesleukin, into critical Phase 3 clinical trials for atopic dermatitis and alopecia areata.
Southfield-based automotive supplier Lear Corporation will distribute a quarterly cash dividend of $0.77 per share to its common stockholders. The payout, confirmed by the company’s Board of Directors this week, reflects the firm's ongoing capital return strategy for its global base of investors and institutional partners.
Globant reported second-quarter revenue of $614.4 million, a figure effectively flat compared to the same period last year, as the company pivots toward an AI-driven consumption model. CEO Martín Migoya signaled a departure from traditional hourly billing, betting on its new platform to capture enterprise demand.
